Clinical Lymphoma, Myeloma & Leukemia is the official journal of the International Myeloma Society. CLML publishes original articles describing various aspects of clinical and translational research.

If you are interested in publishing clinical or translational research in Clinical Lymphoma, Myeloma & Leukemia, please contact a member of the myeloma editorial board.

Senior Editor-in-Chief

Sundar Jagannath, MD
The Mount Sinai Hospital, New York, New York, United States of America

Editor-in-Chief, Myeloma

Sagar Lonial, MD
Emory University, Atlanta, Georgia, United States of America

Associate Editors

Ajai Chari, MD University of California, San Francisco, California, United States of America
Mariateresa Fulciniti, PhD Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
Morie Gertz, MD Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States of America
Amrita Krishnan, MD City of Hope Beckman Research Institute, Duarte, California, United States of America
Roberto Mina, MD University Hospital City of Science and Health Turin, Torino, Italy
Enrique Ocio, MD, PhD University Hospital of Salamanca, Salamanca, Spain
Evangelos Terpos, MD, PhD National and Kapodistrian University of Athens, Athens, Greece

Myeloma Editorial Board

Name Affiliation/Location
Meral Beksac, MD Ankara, Turkey
Wee Joo Chng, MD Singapore
Mattia D’Agostino, MD  Torino, Italy
Michel Delforge, MD, PhD Leuven, Belgium
Hermann Einsele, MD Würzburg, Germany
Efstathios Kastritis, MD Athens, Greece
Xavier Leleu, MD, PhD Poitiers, France
Philippe Moreau, MD Nantes, France
E. Paola Neri, MD, PhD Calgary, Alberta, Canada
Charlotte Pawlyn, MD London, United Kingdom
Hang Quach, MD Melbourne, Australia
Karthik Ramasamy, MD Oxford, United Kingdom
Joshua Richter, MD New York, New York, United States of America
Fredrik Schjesvold, MD Oslo, Norway
Cyrille Touzeau, MD, PhD Nantes, France
Sonja Zweegman, MD, PhD Amsterdam, Netherlands

Claim your subscription today!

All members of IMS are entitled to a free online subscription to the Clinical Lymphoma, Myeloma & Leukemia. 

Instructions to access and claim your subscription is as follows:

Step 1: Go to

Step 2: Click Log in and sign in using your credentials (Skip this and go to step 3 for first time registrants/users).

Step 3: Please click on Register at the top right corner of the home page. Enter your preferred e-mail address and all the requested details.

Step 4: Once registered and/or signed in, click Claim at the top right corner of the home page.

Step 5: Enter the code CLMLIMS on the Account Number field. Leave the ‘Last Name’ blank and do NOT tick ‘I receive a subscription as a Qualified Recipient of the US print edition’.

Step 6 : Click Activate Claim.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events